Öz
Miyokard perfüzyon sintigrafisi (MPS), koroner arter hastalığında temel görüntüleme yöntemi haline gelmiştir. Günümüzde MPS; tanı, risk değerlendirmesi, canlı doku var- lığı ve sol ventrikül fonksiyonlarının değerlendirilmesi de dahil koroner kalp hastalığının tüm aşamalarının değerlendirilmesi için kullanışlıdır. Bu makalenin amacı; görüntüleme protokolleri, stres protokolleri ve koroner arter hastalığında uygulama alanları da dahil miyokard perfüzyon sintigrafisinin kardiyoloji pratiğindeki yerinin gözden geçirmektir.
Anahtar kelimeler: Miyokard perfüzyon sintigrafisi, Koroner arter hastalığı; Kardiyoloji
ABSTRACT
Myocardial perfusion scintigraphy (MPS) has become established as the main functional cardiac imaging method for coronary artery disease. It is currently appropriate for all aspects of detecting and managing coronary heart disease, including diagnosis, risk assessment and stratification, assessment of myocardial viability, and evaluation of left ventricular function. The purpose of this article was to review myocardial perfusion scintigraphy in cardiology practice including imaging protocols, stres protocols and main application fields.
Keywords: Myocardial perfusion scintigraphy; Coronary artery disease; Cardiology
Anahtar Kelimeler
Miyokard perfüzyon sintigrafisi Koroner arter hastalığı Kardiyoloji
Kaynakça
- Dowsley T, Al-Mallah M, Ananthasubramaniam K, Dwivedi G, McArdle B, Chow BJ. The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making. Can J Cardiol. 2013;29 (3):285-96.
- Oommen SS, Nuclear cardiac imaging. In: Griffin BP ed, Manual of Cardiovascular Medicine. Fourt Edition, Philidelphia, USA. Lipincott William Wilkins, 2013:p.791-807
- Won KS, Song BI. Recent Trends in Nuclear Cardiology Practice. Chonnam Med J. 2013;49 (2):55-64.
- Lebowitz E, Greene MW, Fairchild R, Bradley-Moore PR, Atkins HL, Ansari AN, et al. Thallium-201 for medical use. I. J Nucl Med 1975;16 (1):151-5.
- Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, Jager PL. Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imaging. 2006;22 (1):63-80.
- Kailasnath P, Sinusas AJ. Technetium-99m-labeled myocardial perfusion agents: Are they better than thallium-201 ? Cardiol Rev. 2001;9 (3):160-72.
- Udelsen JE, Dilsizian V, Bonow RO. Nuclear Cardiology. In:Bonow RO, Mann DL, Zipes DP, Libby P eds, Braunwald’s Heart Disease, Ninth Edition, Philidelphia, USA. Elsevier Saunders, 2012:p. 293-339.
- Mc Ardle B, Ziadi MC, Ruddy TD, Beanlands RS. Nuclear perfusion imaging for functional evaluation of patients with known or suspected coronary artery disease: the future is now. Future Cardiol. 2012;8 (4):603-22.
- Caobelli F, Pizzocaro C, Paghera B, Guerra UP. Evaluation of patients with coronary artery disease. IQ-SPECT protocol in myocardial perfusion imaging: Preliminary results. Nuklearmedizin. 2013;52 (5):178-85.
- Slomka PJ, Berman DS, Germano G. New Imaging Protocols for New Single Photon Emission CT Technologies. Curr Cardiovasc Imaging Rep. 2010;3 (3):162-170.
- Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac
- Radionuclide Imaging). Circulation. 2003;108 (11):1404-18.
- Zhang L, Tian YQ, Zhang XL, Sun XX, Guo F, Wei HX et al. Left ventricular functional changes after adenosine vasodilator stress evaluated by gated single-photon emission computed tomography. Cardiology. 2013;125 (2):104-9.
- Akıncıoğlu Ç, Atasever T, Caner B, Çapa Kaya G, Kıraç S, Ünlü M. Nükleer Kardiyoloji Uygulama Kılavuzu. TJNM 2001; 10, 4(S): 41
- Friedman M, Spalding J, Kothari S, Wu Y, Gatt E, Boulanger L. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole. J Med Econ. 2013;16 (4):449-60
- Jacqueminet S, Barthelemy O, Rouzet F, Isnard R, Halbron M, Bouzamondo A, et al. A randomized study comparing isotope and echocardiography stress testing in the screening of silent myocardial ischaemia in type 2 diabetic patients. Diabetes Metab. 2010;36 (6 Pt 1):463-9.
- Lima RS, De Lorenzo A, Machado LS, Oliveira BN, Pellini MP. A new myocardial perfusion scintigraphy stress protocol combining dipyridamole-dobutamine-atropine. Nucl Med Commun. 2012;33 (3):239-45.
- Allman KC, Shaw LJ, HachamoviTeknesyumh R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39 (7):1151–8.
- Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of
- Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol. 2007;50 (27):2264-74.
- Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of
Öz
Myocardial perfusion scintigraphy (MPS) has become established as the main functional cardiac imaging method for coronary artery disease. It is currently appropriate for all aspects of detecting and managing coronary heart disease, including diagnosis, risk assessment and stratification, assessment of myocardial viability, and evaluation of left ventricular function. The purpose of this article was to review myocardial perfusion scintigraphy in cardiology practice including imaging protocols, stres protocols and main application fields
Anahtar Kelimeler
Myocardial perfusion scintigraphy Coronary artery disease; Cardiology
Kaynakça
- Dowsley T, Al-Mallah M, Ananthasubramaniam K, Dwivedi G, McArdle B, Chow BJ. The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making. Can J Cardiol. 2013;29 (3):285-96.
- Oommen SS, Nuclear cardiac imaging. In: Griffin BP ed, Manual of Cardiovascular Medicine. Fourt Edition, Philidelphia, USA. Lipincott William Wilkins, 2013:p.791-807
- Won KS, Song BI. Recent Trends in Nuclear Cardiology Practice. Chonnam Med J. 2013;49 (2):55-64.
- Lebowitz E, Greene MW, Fairchild R, Bradley-Moore PR, Atkins HL, Ansari AN, et al. Thallium-201 for medical use. I. J Nucl Med 1975;16 (1):151-5.
- Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, Jager PL. Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imaging. 2006;22 (1):63-80.
- Kailasnath P, Sinusas AJ. Technetium-99m-labeled myocardial perfusion agents: Are they better than thallium-201 ? Cardiol Rev. 2001;9 (3):160-72.
- Udelsen JE, Dilsizian V, Bonow RO. Nuclear Cardiology. In:Bonow RO, Mann DL, Zipes DP, Libby P eds, Braunwald’s Heart Disease, Ninth Edition, Philidelphia, USA. Elsevier Saunders, 2012:p. 293-339.
- Mc Ardle B, Ziadi MC, Ruddy TD, Beanlands RS. Nuclear perfusion imaging for functional evaluation of patients with known or suspected coronary artery disease: the future is now. Future Cardiol. 2012;8 (4):603-22.
- Caobelli F, Pizzocaro C, Paghera B, Guerra UP. Evaluation of patients with coronary artery disease. IQ-SPECT protocol in myocardial perfusion imaging: Preliminary results. Nuklearmedizin. 2013;52 (5):178-85.
- Slomka PJ, Berman DS, Germano G. New Imaging Protocols for New Single Photon Emission CT Technologies. Curr Cardiovasc Imaging Rep. 2010;3 (3):162-170.
- Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac
- Radionuclide Imaging). Circulation. 2003;108 (11):1404-18.
- Zhang L, Tian YQ, Zhang XL, Sun XX, Guo F, Wei HX et al. Left ventricular functional changes after adenosine vasodilator stress evaluated by gated single-photon emission computed tomography. Cardiology. 2013;125 (2):104-9.
- Akıncıoğlu Ç, Atasever T, Caner B, Çapa Kaya G, Kıraç S, Ünlü M. Nükleer Kardiyoloji Uygulama Kılavuzu. TJNM 2001; 10, 4(S): 41
- Friedman M, Spalding J, Kothari S, Wu Y, Gatt E, Boulanger L. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole. J Med Econ. 2013;16 (4):449-60
- Jacqueminet S, Barthelemy O, Rouzet F, Isnard R, Halbron M, Bouzamondo A, et al. A randomized study comparing isotope and echocardiography stress testing in the screening of silent myocardial ischaemia in type 2 diabetic patients. Diabetes Metab. 2010;36 (6 Pt 1):463-9.
- Lima RS, De Lorenzo A, Machado LS, Oliveira BN, Pellini MP. A new myocardial perfusion scintigraphy stress protocol combining dipyridamole-dobutamine-atropine. Nucl Med Commun. 2012;33 (3):239-45.
- Allman KC, Shaw LJ, HachamoviTeknesyumh R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39 (7):1151–8.
- Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of
- Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol. 2007;50 (27):2264-74.
- Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of
Ayrıntılar
| Bölüm | Derleme |
|---|---|
| Yazarlar | |
| Yayımlanma Tarihi | 27 Şubat 2015 |
| Yayımlandığı Sayı | Yıl 2015 Cilt: 5 Sayı: 1 |
